C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions

Several studies have associated the presence of residual insulin secretion capability (also referred to as being C-peptide positive) with lower risk of insulin-induced hypoglycemia in patients with type 1 diabetes (T1D), although the reason is unclear. We tested the hypothesis that C-peptide infusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Mary Courtney, Warner, Shana O., Dai, Yufei, Sheanon, Nicole, Smith, Marta, Farmer, Ben, Cason, Rebecca L., Cherrington, Alan D., Winnick, Jason J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262495/
https://www.ncbi.nlm.nih.gov/pubmed/34003799
http://dx.doi.org/10.1172/jci.insight.148997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262495/
https://www.ncbi.nlm.nih.gov/pubmed/34003799
http://dx.doi.org/10.1172/jci.insight.148997

Ejemplares similares